GlassScriptPhysician profile
Cheri L Coyle
NPI 1992712277
$3,295.08
in general payments reported to CMS, 2019-2025
38 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $643 · 2021: $390 · 2022: $474 · 2023: $627 · 2024: $433 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $775.94 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $393.38 | 2023-2025 | Gemtesa, Myfembree |
| Amgen INC. | $325.95 | 2019-2025 | Evenity, Prolia, Prolia |
| Myovant Sciences INC. | $197.61 | 2021-2022 | |
| Daiichi Sankyo INC. | $166.55 | 2019-2024 | Injectafer |
| Abbvie INC. | $159.33 | 2019-2022 | |
| Pfizer INC. | $156.45 | 2019-2024 | |
| Minerva Surgical, INC | $129.68 | 2019-2024 | |
| Optumhealth Care Solutions, LLC | $73.71 | 2023 | Vivify Health Care Team Portal |
| Bayer Healthcare Pharmaceuticals INC. | $72.72 | 2021-2025 | |
| Coloplast Corp | $67.09 | 2023-2024 | Saffron, Altis |
| Aspira Women'S Health INC | $64.98 | 2022-2023 | Ova1 |
| Organon LLC | $55.19 | 2021-2024 | Nexplanon |
| Urovant Sciences INC | $53.01 | 2022 | |
| Biogen, INC. | $51.58 | 2025 | Zurzuvae |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $50.34 | 2020-2022 | |
| Amag Pharmaceuticals, INC. | $46.14 | 2019 | |
| Scynexis, INC. | $44.26 | 2022 | |
| Hologic Sales and Service, LLC | $37.77 | 2019-2023 | Acessa Provu System |
| Coopersurgical, INC. | $37.60 | 2022-2024 | Paragard T 380a |
| Exeltis, USA INC. | $32.58 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $32.43 | 2019 | |
| Vertical Pharmaceuticals, LLC | $27.85 | 2019 | |
| Boston Scientific Corporation | $23.23 | 2023 | Solyx Sis System |
| Agile Therapeutics, INC. | $21.82 | 2021 | |
| Allergan, INC. | $20.92 | 2020 | |
| Meditrina | $20.45 | 2023-2024 | |
| Evofem Biosciences, INC. | $17.84 | 2022 | |
| Axonics, INC. | $16.56 | 2022 | |
| Ascend Therapeutics US, LLC | $16.54 | 2022 | |
| Lupin INC. | $14.39 | 2019 | |
| Mayne Pharma Commercial LLC | $14.31 | 2021 | |
| Novo Nordisk INC | $13.88 | 2020 | |
| Bard Access Systems, INC. | $13.57 | 2019 | |
| Shield Therapeutics INC | $13.51 | 2023 | Accrufer |
| Avion Pharmaceuticals | $13.51 | 2022 | |
| Ethicon US, LLC | $11.35 | 2020 | |
| Covidien LP | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheri Coyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.